Abstract Purpose of Review Multiple guidelines and recommendations have been written to
address the perioperative management of antiplatelet and anticoagulant drugs. In this …

This review is a historical account about purinergic signalling in the heart, for readers to see
how ideas and understanding have changed as new experimental results were published …

Although most physicians are comfortable managing the limited anticoagulant effect of
aspirin, the recent administration of potent P2Y 12 receptor inhibitors in patients undergoing …

Objective To review systematically the evidence and perform a meta-analysis of benefits and
risks associated with use of P2Y12 receptor inhibitors in coronary artery bypass graft-, non …

Antiplatelet drugs are prescribed to prevent arterial thrombosis and especially the
recurrence of thrombotic events. The four main oral antiplatelets have two distinct …

Up to 11% of patients presenting with acute coronary syndromes undergo coronary artery
bypass grafting. Guidelines largely recommend a one-size-fits-all preoperative …

Abstract The French Working Group on Perioperative Haemostasis (GIHP) and the French
Study Group on Haemostasis and Thrombosis (GFHT) in collaboration with the French …

Summary The French Working Group on Perioperative Haemostasis (GIHP) and the French
Study Group on Haemostasis and Thrombosis (GFHT), in collaboration with the French …

Résumé Le Groupe d'intérêt en hémostase périopératoire (GIHP) et le Groupe français
d'études sur l'hémostase et la thrombose (GFHT), en collaboration avec la Société française …

Objectives This study sought to determine (1) the association between the length of
preoperative clopidogrel discontinuation, blood loss, and transfusion requirements and (2) …